Johnson & Johnson’s (JNJ) revenue rose 13% to $15.1 billion in Q2. However, if revenue from the purchase of Pfizer’s consumer healthcare business was accounted for, the topline would have been up only 3.6%.
Revenue at the company’s medical device business was up 5.1%. Its pharma business rose 4.8%.
The company’s overall net margin fell slightly to 20.4%.
Douglas A. McIntyre
It’s Your Money, Your Future—Own It (sponsor)
Retirement can be daunting, but it doesn’t need to be.
Imagine having an expert in your corner to help you with your financial goals. Someone to help you determine if you’re ahead, behind, or right on track. With SmartAsset, that’s not just a dream—it’s reality. This free tool connects you with pre-screened financial advisors who work in your best interests. It’s quick, it’s easy, so take the leap today and start planning smarter!
Don’t waste another minute; get started right here and help your retirement dreams become a retirement reality.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.